Term ends no later than Mar 9, 2039 · Medium confidence
20-year base term ends Oct 23, 2038
In force on USPTO's status record and by its fee record. A terminal disclaimer on file may shorten this term, possibly to a date already past; its reference document is unresolved, so the date above is an upper bound and no earlier date is guessed.
Oct 23, 2018
Mar 9, 2039
Apr 16, 2024
This patent's term runs 137 days past its 20-year base term on prosecution delay. A terminal disclaimer is on file with no resolved reference, so no cap is applied and none is guessed. 0 of 3 maintenance fees are paid so far. Confidence: Medium. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Oct 23, 2018, when application 16/168,823, the earliest non-provisional in its chain, was filed (this one was filed Nov 24, 2020) | Oct 23, 2038 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +137 days, USPTO patent term adjustment record | Mar 9, 2039 | High confidence |
| Terminal disclaimer cap | Disclaimer on file (approved), reference document not resolved | no cap applied, and none guessed | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | no later than Mar 9, 2039 | Medium confidence |
This family
| US 10,899,843 | In force Mar 2039 | Mar 2039 |
| US 11,958,908 | this patent no later than Mar 2039 | no later than Mar 2039 |
| Application 18/626,765 | Pending not computed | not computed |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| May 2, 2023 Reel 63517, frame 97 | Magenta Therapeutics, Inc. | Crispr Therapeutics AG | Assignment of Assignor's Interest |
| Jun 1, 2023 Reel 63821, frame 7 | Pearse, Bradley R.; Cooke, Michael; Boitano, Anthony; Palchaudhuri, Rahul; McDonough, Sean; Panwar, Rajiv | Magenta Therapeutics, Inc. | Assignment of Assignor's Interest |
| Jun 1, 2023 Reel 63821, frame 36 | Glanville, Jacob | Distributed Bio, Inc. | Assignment of Assignor's Interest |
| Jun 5, 2023 Reel 63851, frame 896 | Distributed Bio, Inc. | Magenta Therapeutics, Inc. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer is on file (approved) and its reference document is not resolved. A disclaimer would cap the term earlier than Mar 9, 2039. We will not guess the cap.